These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12030947)

  • 21. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
    Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in birth-cohort pattern of peptic ulcer mortality in England and Wales.
    Katschinski BD; Logan RF
    Postgrad Med J; 1991 Sep; 67(791):825-8. PubMed ID: 1946128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid-related disorders in the elderly.
    Franceschi M; Di Mario F; Leandro G; Maggi S; Pilotto A
    Best Pract Res Clin Gastroenterol; 2009; 23(6):839-48. PubMed ID: 19942162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori eradication for peptic ulceration: an observational study in a Scottish primary care setting.
    Forrest EH; MacKenzie JF; Stuart RC; Morris AJ
    Scott Med J; 2002 Apr; 47(2):28-33. PubMed ID: 12058660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitor prescribing patterns in the UK: a primary care database study.
    Othman F; Card TR; Crooks CJ
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1079-87. PubMed ID: 27255671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database.
    Majeed A; Moser K; Carroll K
    Heart; 2001 Sep; 86(3):284-8. PubMed ID: 11514479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Audit of proton pump inhibitor (PPI) prescribing: are NICE guidelines being followed?
    Arasaradnam RP; Woodward T; Parrack L; Bartlett J; Bolton RP
    Clin Med (Lond); 2003; 3(4):387-8. PubMed ID: 12938761
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptic ulcer perforation before and after the introduction of H2-receptor blockers and proton pump inhibitors.
    Hermansson M; Staël von Holstein C; Zilling T
    Scand J Gastroenterol; 1997 Jun; 32(6):523-9. PubMed ID: 9200281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 20 years of hospital admissions for peptic ulcer in England and Wales.
    Coggon D; Lambert P; Langman MJ
    Lancet; 1981 Jun; 1(8233):1302-4. PubMed ID: 6112615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescribing policy for antiulcer treatment in the elderly.
    Bianchi Porro G; Lazzaroni M
    Drugs Aging; 1993; 3(4):308-19. PubMed ID: 8369591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptic disease: can we afford current management?
    Fletcher DR
    Aust N Z J Surg; 1997; 67(2-3):75-80. PubMed ID: 9068546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs?
    Teeling M; Bennett K; Feely J
    Br J Clin Pharmacol; 2004 Mar; 57(3):337-43. PubMed ID: 14998430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical therapy of the peptic ulcer in a hospital specializing in gastroenterology. Effects of therapy with h2 antagonists].
    Lorusso D; Pezzolla F; Lantone G; Misciagna G; Guerra V
    Minerva Chir; 1997 Nov; 52(11):1293-7. PubMed ID: 9489325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical issues in the pathophysiology and management of peptic ulcer disease.
    Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic acid-related disorders are common and underinvestigated.
    Majumdar SR; Soumerai SB; Farraye FA; Lee M; Kemp JA; Henning JM; Schrammel P; LeCates RF; Ross-Degnan D
    Am J Gastroenterol; 2003 Nov; 98(11):2409-14. PubMed ID: 14638341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisecretory therapy for bleeding peptic ulcer.
    Peterson WL; Cook DJ
    JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.
    Lazzaroni M; Bianchi Porro G
    Drugs Aging; 1996 Oct; 9(4):251-61. PubMed ID: 8894523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.